• 1. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 2. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 3. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 4. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

Recent Advances in the Study of 1-Cyanocyclopropane-1-carboxamide (CAS: 1559-04-2) in Chemical Biology and Pharmaceutical Research

1-Cyanocyclopropane-1-carboxamide (CAS: 1559-04-2) has emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have focused on its synthesis, biological activity, and mechanism of action, providing valuable insights for drug discovery and development. This research brief consolidates the latest findings related to this compound, highlighting its role in modern medicinal chemistry.

The synthesis of 1-Cyanocyclopropane-1-carboxamide has been optimized in recent years, with novel methodologies improving yield and purity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated an efficient one-pot synthesis route using cyclopropanation followed by cyanamide functionalization, achieving a 78% yield. This advancement is particularly relevant for scalable production, addressing previous challenges in large-scale synthesis.

In terms of biological activity, 1-Cyanocyclopropane-1-carboxamide has shown promising results as a modulator of enzymatic function. Research from the University of Cambridge (2024) identified its potent inhibitory effects on certain cysteine proteases, with IC50 values in the low micromolar range. This suggests potential applications in treating conditions where protease regulation is crucial, such as inflammatory diseases and certain cancers.

The compound's mechanism of action appears to involve both covalent and non-covalent interactions with biological targets. Structural studies using X-ray crystallography (Nature Chemical Biology, 2023) revealed that the cyano group forms reversible covalent bonds with active site residues, while the cyclopropane ring induces conformational changes in target proteins. This dual mode of action makes it particularly interesting for developing targeted therapies.

Recent preclinical studies have explored the pharmacokinetic properties of 1-Cyanocyclopropane-1-carboxamide derivatives. A 2024 report in Drug Metabolism and Disposition showed improved metabolic stability compared to earlier analogs, with a half-life extension of approximately 40% in murine models. These findings support further investigation of this compound class as potential drug candidates.

In the context of drug discovery, several pharmaceutical companies have included 1-Cyanocyclopropane-1-carboxamide scaffolds in their screening libraries. Patent filings from 2023-2024 indicate growing interest in its application for neurological disorders, with particular focus on its ability to cross the blood-brain barrier. The compound's relatively small molecular weight and balanced lipophilicity contribute to this favorable property.

Future research directions for 1-Cyanocyclopropane-1-carboxamide include exploring its potential in combination therapies and further optimizing its selectivity profile. The compound's versatility as a chemical building block continues to attract attention from both academic and industrial researchers, positioning it as a valuable tool in medicinal chemistry and chemical biology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)